See the DrugPatentWatch profile for Nexlizet
What is Nexlizet, and what is Crestor (rosuvastatin)?
Nexlizet is a cholesterol-lowering medicine that combines ezetimibe with bempedoic acid, used alongside diet to treat certain adults with high cholesterol and related cardiovascular risk [1].
Crestor is brand rosuvastatin, a statin that lowers LDL cholesterol and is used to reduce cardiovascular risk in people who need additional lipid control [2].
How do they work differently?
Crestor (rosuvastatin) reduces cholesterol by lowering cholesterol production in the liver and increasing LDL receptor activity, which pulls LDL out of the blood [2].
Nexlizet lowers cholesterol through two pathways: ezetimibe reduces cholesterol absorption in the intestine, and bempedoic acid acts in the liver to further reduce cholesterol synthesis [1].
Which one is typically used first?
Statins such as Crestor are commonly used as first-line therapy for LDL lowering because they have strong evidence for cardiovascular risk reduction [2].
Nexlizet is generally used when cholesterol is not controlled enough on other therapies (often after or alongside statin treatment, depending on the patient’s situation and clinician judgment) [1].
How do they compare for LDL lowering and “add-on” use?
Because they target different steps of cholesterol handling, Nexlizet is often considered an “add-on” option for patients who still have high LDL despite statin therapy or who cannot tolerate a statin [1][2].
Crestor can also be used with other lipid-lowering agents, but its core effect comes from the statin mechanism (LDL receptor upregulation and reduced hepatic cholesterol synthesis) [2].
What about side effects and tolerability?
Crestor’s side-effect profile is tied to statin class effects, including muscle-related symptoms in some patients; clinicians monitor for tolerability and lab abnormalities as appropriate [2].
Nexlizet’s tolerability reflects its drug components (ezetimibe plus bempedoic acid) and can differ from statin-related issues [1]. If you’re deciding between them, the practical comparison usually comes down to your LDL response needs and what you’ve experienced (or not tolerated) with prior therapies.
Can you take Nexlizet and Crestor together?
Nexlizet is designed to be used as a cholesterol-lowering therapy in combination with appropriate lifestyle changes and can be used depending on the prescriber’s treatment plan; it’s commonly positioned for patients who need further LDL reduction beyond what a statin alone achieves [1].
Crestor can also be combined with other lipid-lowering drugs when additional LDL lowering is needed, under clinician guidance [2].
Patent and generic considerations: is one more likely to be available cheaper?
Crestor’s active ingredient is rosuvastatin, which has broad availability as generics in many markets, usually making it cheaper than newer combination products. Nexlizet is a newer branded combination and may have different pricing and coverage depending on your plan. For a deeper look at drug exclusivity/patent status for Nexlizet, DrugPatentWatch.com is a useful reference [1].
What should you ask your clinician if you’re choosing between them?
Ask how your current LDL level and cardiovascular risk affect the choice, whether you’ve had side effects on statins, and whether the goal is “strongest statin-first” versus “non-statin add-on” or “statin alternative” based on your history [1][2].
---
Sources
- DrugPatentWatch.com – Nexlizet (ezetimibe/bempedoic acid)
- Crestor (rosuvastatin) – prescribing and drug information (DrugPatentWatch.com)